An IRB member's perspective on access to innovative therapy
- PMID: 11652854
Item in Clipboard
An IRB member's perspective on access to innovative therapy
Albany Law Rev.
1994.
No abstract available
Similar articles
-
Regulatory orphans: juvenile prisoners as transvulnerable research subjects.IRB. 1999 Mar-Apr;21(2):9-14. IRB. 1999. PMID: 11657875 No abstract available.
-
The changing clinical trials scene: the role of the IRB.IRB. 1988 Jul-Aug;10(4):1-5. IRB. 1988. PMID: 11650078 No abstract available.
-
The IRB's role in assessing the generalizability of non-NIH-funded clinical trials.IRB. 1998 Mar-Jun;20(2-3):1-5. IRB. 1998. PMID: 11656912 No abstract available.
-
Regulating research on the terminally ill: a proposal for heightened safeguards.J Contemp Health Law Policy. 1999 Spring;15(2):479-524. J Contemp Health Law Policy. 1999. PMID: 10394764 Review. No abstract available.
-
Cognitively impaired subjects. American College of Physicians.Ann Intern Med. 1989 Nov 15;111(10):843-8. Ann Intern Med. 1989. PMID: 2683918 Review. No abstract available.
Cited by
-
Determining what we stand for will guide what we do: community priorities, ethical research paradigms, and research with vulnerable populations.Am J Public Health. 2009 Feb;99(2):201-4. doi: 10.2105/AJPH.2008.125617. Am J Public Health. 2009. PMID: 19141599 Free PMC article.